Reportlinker.com announces that a new market research report is available in its catalogue: “Global Sleep Apnea Diagnostic And Therapeutic Devices Industry”. 

This report analyzes the worldwide markets for Sleep Apnea Diagnostic and Therapeutic Devices in US$ Million by the following Product Segments: Diagnostic Devices (Fixed PSG, Ambulatory PSG, & Others (include Screening Devices)), and Therapeutic Devices (CPAP, Bi-Level PAP, Auto PAP, & Facial Interfaces (Masks and Humidifiers)). Read the rest of this entry

SleepApneaDisorder/ [ Press Release ]/ GURNEE, IL, November 08, 2010 /– Smashed Face Syndrome can be caused by long term use of CPAP for sleep apnea. The following is excerpted from Sleep and Health Journal. 

Sleep apnea is a serious and dangerous disorder that can cause a wide variety of illness and dysfunction. CPAP is considered the Gold Standard of treatment for sleep apnea and the first line treatment for severe sleep apnea. For mild to moderate sleep apnea CPAP and Oral Appliances are considered to be the first lines of treatment. 

Numerous studies attest to the efficacy of Continuous Positive Airway Presssure (CPAP) for treating sleep apnea. Unfortunately, there are numerous articles relating to CPAP failure due to non-compliance. A recent study showed 60% of patients abandon CPAP therapy entirely and that even among patients who utilize CPAP average compliance is only 4-5 hours a night 4-5 nights a week.  Read the rest of this entry

SleepApneaDisorder/[ Press Reease ]/ The US leads the global sleep apnea market and accounts for a major share of the global market. Favorable reimbursement changes and development in Home Sleep Testing are likely to provide further impetus to the market in the US. The region’s sleep apnea market continues to grow at a steady pace, despite the economic bottlenecks that adversely affected the performance of healthcare market in recent years. Therapeutic Devices dominate the overall sleep apnea market. By the year 2015, CPAP Devices market in the US is projected to cross US$1.0 billion. In Europe, around 20 million people are affected by long-term, chronic sleep disorders. In addition, around 10 million people experience intermittent sleeping trouble. Growth in patient population in Europe is supported by the increasing cases of obesity and ageing population. European market for Sleep Apnea Diagnostic Devices is projected to reach US$114 million by 2013. Read the rest of this entry

Eighty-one percent of hospital patients are at high risk for obstructive sleep apnea, a Loyola University Health System study has found.  

The findings suggest that hospitals should consider giving patients a five-minute screening test to identify those who are at high risk. 

Sleep specialist Dr. Sunita Kumar and colleagues administered an eight-question obstructive sleep apnea screening questionnaire known as STOP-BANG to patients during a single day at Loyola University Hospital.

Patients were excluded if they were on a breathing tube, on sedatives or had an altered mental status. 

Of the 195 patients surveyed, 157, or 80.5 percent, were at high risk for obstructive sleep apnea, meaning they answered “Yes” to at least three questions on the questionnaire.  Read the rest of this entry

A study out of Morristown memorial hospital in New Jersey found a group of golfers that improved their golf game by up to three strokes. Granted, these golfers suffered from sleep apnea and were users of the C-PAP sleep apnea headhear, a continuous positive airway pressure mask that helps them sleep better. (Read More…  )

If you or any of your family members suffering you are encouraged to attend the A.W.A.K.E. support group meeting on Monday, November 1 from 6 p.m. to 8 p.m. at the Parrish Healthcare Center at Port St. John, 5005 Port St. John Parkway, (east of the I-95 Port St. John exit – see map). The meetings are held in the Conference Center by the south entrance (near the sleep lab). This is a free community service. Please call 321-268-6408 to register.

You will learn how to wear your CPAP all night and be comfortable with it. CPAP is an important treatment for sleep apnea, but it’s not without its frustrations. Learn how to avoid uncomfortable masks and other common CPAP problems. Read the rest of this entry

San Diego — As health officials continue to monitor the physical and monetary toll sleep disorders exact in the U.S., treating various conditions brought on by sleep problems has transformed snoozing into a sound business for a San Diego-based medical device manufacturer.

And the market of potential customers has yet to be fully realized, said officials at ResMed, a sleep apnea device maker with about 325 local employees.

In addition to announcing record revenues recently, ResMed is teaming up with a major competitor to educate the medical community in a $1 million campaign to help reach millions of undiagnosed Americans with sleeping disorders, especially sleep apnea. Read the rest of this entry

SleepApneaDisorder/[Press Release]/-What is the best sleep apnea treatment? It is not CPAP, according to a recent study that showed 60% of patients abandon CPAP use. At least it is not the best treatment for the 60% of patients who abandoned it. This does not mean CPAP is not the most effective treatment, what it means is no matter how effective a treatment may be, it is a poor treatment if it is not used. Oral appliances are an extremely effective treatment for mild to moderate sleep apnea but less effective for morbidly obese patients and those with severe sleep apnea. Read the rest of this entry

Do you suffer from sleep apnea or have a family member or friend who suffers from it? If so, you are encouraged to attend this support group meeting on Monday, August 2 from 6 p.m. to 8 p.m. at the Parrish Healthcare Center at Port St. John, 5005 Port St. John Parkway, (east of the I-95 Port St. John exit – see map). The meetings are held in the Conference Center by the south entrance (near the sleep lab). This is a free community service. Please call 321-268-6408 to register.  

At the August A.W.A.K.E. Support Group meeting you will learn about healthy eating from Board-Certified Geriatrician Pamela Tronetti, DO, AGSF, medical director of the Parrish Senior Consultation Center and the future Parrish Health Village.   Read the rest of this entry

Philips Respironics ComfortGel Blue nasal mask is used in the treatment of obstructive sleep apnea (OSA).  Based on the company’s popular blue gel masks, this product is designed to help enhance patient comfort and compliance. 
 
Retaining the comfort and flexibility features found in previous gel masks, ComfortGel Blue incorporates several new features to make it the next generation of comfort and technology.  Included in this new product are an improved forehead pad designed to help reduce pressure points, a lower profile exhalation port with an integrated swivel that quietly directs air flow up and away from a bed partner, and a new gel cushion that gently conforms to facial features.  Used together with Philips Respironics System One Resistance Control, the mask will help deliver optimum PAP therapy and comfort. Read the rest of this entry

[Press Release]-Circadiance, the world leader in soft cloth nasal CPAP masks, has launched the SleepWeaver(R) in the European Union and will launch in Canada soon. The company has secured the right to apply the CE Mark after becoming ISO 13485 certified.

“Sleep Apnea affects tens of millions of people around the world,” said David Groll, Circadiance’s CEO. “We have already established distributors in several European countries in preparation for this launch, and we anticipate the same enthusiastic reception in these new markets that we have enjoyed in the U.S. Our soft cloth mask is the answer to uncomfortable hard plastic masks that foster noncompliance. This milestone is just another step in our effort to establish global distribution for our superior cloth CPAP mask technology.” Read the rest of this entry